financetom
Business
financetom
/
Business
/
Textile, 3Box Labs Merge in Decentralized Data Tie-Up for AI Agents
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Textile, 3Box Labs Merge in Decentralized Data Tie-Up for AI Agents
Feb 5, 2025 9:20 AM

Two venture-backed veterans of crypto's data storage subsector, Textile and 3Box Labs, the builder of Ceramic, have merged in an all-stock deal, CoinDesk has learned.

The companies will operate under Textile's brand and retain their staff and data infrastructure- focused product lines. Textile CEO Andrew Hill will head the merged organization.

Self-described "friendly competitors," Textile and 3Box Labs raised funds from the same VC firms and offered overlapping products, 3Box Labs co-founder Michael Sena said. Between them, the companies have raised at least $42 million since 2019.

"We came to the conclusion that the future we're building toward is an identical one," he said in an interview.

That future is one where people, companies and, especially, AI agents lean on permissionless blockchain rails for data storage, access and verification. Cheap and accessible data storage is a common tech pain point that some proponents of crypto say tokenized economies can improve.

AI's precipitous rise is putting an even greater spotlight on the subsector, as Textile sees it. Agents — artificial intelligence-powered bots that can make decisions and take actions in pursuit of a goal — are one of crypto's big new infatuations, with potential for trading and more.

All those agents will need data to feed their decisions, however. That's where the newly joined Textile sees its opening. It will build what a press release called "the intelligence layer for the multi-agent economy."

"It's pretty clear that our sweet spot of expertise — how to move, store, share verifiable data on crypto rails — is becoming very relevant to agent builders," said Hill.

He said blockchains offer a natural platform for agents to operate: They speak the "lingua franca" of this tech-driven world. Textile is building a blockchain network atop which agents can interact, access data and even sell alpha amongst themselves.

Of course, the crypto industry's AI minds haven't yet figured out what agents are best-suited to do. Many builders are trying out many different things. Momentum is high, though, Hill said, and progress is coming fast.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
argenx Says FDA Approved Vyvgart Hytrulo for Treatment of Neuromuscular Disorder
argenx Says FDA Approved Vyvgart Hytrulo for Treatment of Neuromuscular Disorder
Jun 24, 2024
04:46 AM EDT, 06/24/2024 (MT Newswires) -- argenx (ARGX) said late Friday the US Food and Drug Administration has approved Vyvgart Hytrulo for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy, a neuromuscular disorder that causes a range of disabling mobility and sensory issues. The approval is based on a clinical trial in which 69% of patients treated...
Exclusive-US prosecutors recommend DOJ criminally charge Boeing as deadline looms
Exclusive-US prosecutors recommend DOJ criminally charge Boeing as deadline looms
Jun 24, 2024
WASHINGTON (Reuters) - U.S. prosecutors are recommending to senior Justice Department officials that criminal charges be brought against Boeing after finding the planemaker violated a settlement related to two fatal crashes, two people familiar with the matter told Reuters. The Justice Department must decide by July 7 whether to prosecute Boeing. The recommendation of prosecutors handling the case has not...
Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators
Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators
Jun 24, 2024
04:36 AM EDT, 06/24/2024 (MT Newswires) -- Takeda (TAK) said Monday that its drug Livtencity has been approved by the Japan's Ministry of Health, Labour and Welfare for the treatment of cytomegalovirus disease that is resistant to existing therapies in patients with transplanted organs. The drug, also known as maribavir, was approved following a phase 3 trial involving 352 patients...
New York Community Bancorp Files Mixed Securities Shelf
New York Community Bancorp Files Mixed Securities Shelf
Jun 24, 2024
04:33 AM EDT, 06/24/2024 (MT Newswires) -- New York Community Bancorp ( NYCB/PU ) filed a registration statement Friday for the potential sale of up to 840 million of its common shares by selling stockholders and 315,000 warrants. The shares comprise of 332.9 million of common stock, 192.0 million of series B convertible preferred stock and 315.0 million of stock...
Copyright 2023-2026 - www.financetom.com All Rights Reserved